1. Home
  2. HCAT vs ANTX Comparison

HCAT vs ANTX Comparison

Compare HCAT & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

HOLD

Current Price

$1.21

Market Cap

121.7M

Sector

Technology

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.91

Market Cap

135.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAT
ANTX
Founded
2008
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.7M
135.4M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
HCAT
ANTX
Price
$1.21
$3.91
Analyst Decision
Hold
Buy
Analyst Count
10
1
Target Price
$2.53
$2.00
AVG Volume (30 Days)
1.0M
3.3M
Earning Date
03-12-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
$311,136,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.48
N/A
52 Week Low
$1.04
$1.00
52 Week High
$5.06
$6.91

Technical Indicators

Market Signals
Indicator
HCAT
ANTX
Relative Strength Index (RSI) 29.47 61.09
Support Level N/A $1.05
Resistance Level $2.45 $6.91
Average True Range (ATR) 0.15 0.87
MACD -0.06 0.12
Stochastic Oscillator 19.37 49.79

Price Performance

Historical Comparison
HCAT
ANTX

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: